Page 426 - 16Neonatal Jaundice_compressed
P. 426

Neonatal jaundice


              Bibliographic   Study Type &   Number of            Intervention & Comparison   Dichotomous outcomes   Continuous Outcomes
              Information    Evidence Level   Patients/Characteristics                       (E:C)             (Mean:SD: N)

              Author:        Methodology:   N:                    Group 1:                   ET:               Max TSB:
              Curtis-Cohen M   RCT          22                    Early Phototherapy         Group 1: 0/11     Group 1: 112 ± 27 micromol/litre
                                                                                             Group 2: 0/11
              Year:          Blinding:      Inclusion:            Group 2:                                     Group 2: 123 ± 20 micromol/litre
              1985           Not reported   Preterm babies        Delayed start of treatment –   Mortality:
                                                                  Phototherapy started at TsB   Group 1: 0/11
              Country:       Randomisation:   Exclusion:          > 85.5micromol/litre       Group 2: 0/11
              USA            Not reported   Haemolytic disease,    Phototherapy consisted of a broad
                                            Direct hyperbilirubinaemia,   spectrum white light from a tungsten-
                149
              ID:            Evidence level:   sepsis             halogen lamp in a Model 1400
                             1 -                                  phototherapy unit.
                                            Demographics:
                                            Gender (M/F) : Not reported   Irradiance was maintained at
                                                                           2
                                            Mean GA: 27.4 ± 1.4 weeks   12microW/cm /nm at 450nm
                                            Mean BW: 858 ± 214 g
                                            Mean age at entry to study: Not
                                            reported
                                            Mean TSB: Not reported
              Author:        Methodology:   N:                    Group 1:                   ET:               Max TSB:
              Leite M        RCT            81                    Early Phototherapy         Group 1: 0/35     Group 1: 113 ± 49 micromol/litre
                                                                                             Group 2: 0/35
              Year:          Blinding:      Inclusion:            Group 2:                                     Group 2: 147 ± 36 micromol/litre
              2004           Not reported   Birthweight < 2000 g   Phototherapy at TsB
                                                                  ≥ 136.8micromol/litre
              Country:       Randomisation:   Exclusion:
              Brazil         Not reported   Haemolysis,
                                            G6PD deficiency,      Phototherapy discontinued at TsB <
                150
              ID:            Evidence level:   Malformations,     85.5micromol/litre
                             1 -            Intestinal obstructions,
                                            Cholestasis, congenital   Phototherapy consisted of fanem Mod
                                            infections,           007 units equipped with 7 Philips
                                            Maternal or neonatal use of   fluorescent lamps (special blue), 400 –
                                            Phenobarbital, TCB    540 nm
                                            > 256.5micromol/litre
                                                                  Average irradiance was
                                                                            2
                                            Demographics:         14.4microW/cm /nm
                                            Gender (M/F) : 37/33
                                            Mean GA: Not reported
                                            Mean BW: Not reported
                                            Mean age at entry to study: Not
                                            reported
                                            Mean TSB: Not reported
              Author:        Methodology:   N:                    Group 1:                                     Max TSB:
              Maurer H       RCT            69                    Agar – 125mg in first 4ml of formula         Group 1: 118 ± 40 micromol/litre
                                                                  beginning at 18 hours and continued at
              Year:          Blinding:      Inclusion:            3 hourly intervals for 4 days                Group 2: 108 ± 36 micromol/litre


            286
   421   422   423   424   425   426   427   428   429   430   431